Literature DB >> 8878188

Increased cytokine gene expression in rat retina following transient ischemia.

M Hangai1, N Yoshimura, Y Honda.   

Abstract

Tumor necrosis factor (TNF) gene expression in rat retina following transient ischemia was studied by semiquantitative reverse transcription-polymerase chain reaction (RT-PCR). Gene expression for other cytokines was also studied by RT-PCR. Although very little expression for TNF gene was detected in normal retina, it was markedly increased 0.5-48 h after reperfusion, with peak expression at 12 h (20-fold of control). Gene expression for interleukin-6, interferon-gamma, and transforming growth factor-beta 1 was also increased. The results provide evidence that retinal ischemia can up-regulate cytokine gene expression in the retina.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878188     DOI: 10.1159/000267910

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  13 in total

1.  Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration.

Authors:  Ruozhou Tom Liu; Jiangyuan Gao; Sijia Cao; Navroop Sandhu; Jing Z Cui; Chai Lin Chou; Edward Fang; Joanne A Matsubara
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-01       Impact factor: 4.799

2.  Decreased retinal neuronal cell death in caspase-1 knockout mice.

Authors:  Jun Arai; Naomichi Katai; Keisuke Kuida; Takanobu Kikuchi; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2006 Sep-Oct       Impact factor: 2.447

3.  Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats.

Authors:  Biji Mathew; Jacqueline N Poston; John C Dreixler; Leianne Torres; Jasmine Lopez; Ruth Zelkha; Irina Balyasnikova; Maciej S Lesniak; Steven Roth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-05-18       Impact factor: 3.117

4.  Progesterone treatment in two rat models of ocular ischemia.

Authors:  Rachael S Allen; Timothy W Olsen; Iqbal Sayeed; Heather A Cale; Katherine C Morrison; Yuliya Oumarbaeva; Irina Lucaciu; Jeffrey H Boatright; Machelle T Pardue; Donald G Stein
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

Review 5.  Cellular mechanisms of blood-retinal barrier dysfunction in macular edema.

Authors:  S A Vinores; N L Derevjanik; H Ozaki; N Okamoto; P A Campochiaro
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

6.  Progesterone treatment shows greater protection in brain vs. retina in a rat model of middle cerebral artery occlusion: Progesterone receptor levels may play an important role.

Authors:  Rachael S Allen; Iqbal Sayeed; Yuliya Oumarbaeva; Katherine C Morrison; Paul H Choi; Machelle T Pardue; Donald G Stein
Journal:  Restor Neurol Neurosci       Date:  2016-11-22       Impact factor: 2.406

7.  Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion.

Authors:  Na Li; Xiao-rong Li; Jia-qin Yuan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-16       Impact factor: 3.117

8.  The effect of thalidomide on vascular endothelial growth factor and tumor necrosis factor-alpha levels in retinal ischemia/reperfusion injury.

Authors:  Semih Aydoğan; Ulkü Celiker; Peykan Türkçüoğlu; Nevin Ilhan; Nusret Akpolat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-09-03       Impact factor: 3.117

9.  Proinflammatory cytokines in a mouse model of central retinal artery occlusion.

Authors:  Michal Kramer; S Dadon; M Hasanreisoglu; Y Monselise; B R Avraham; A Feldman; I Eldar; D Weinberger; N Goldenberg-Cohen
Journal:  Mol Vis       Date:  2009-05-01       Impact factor: 2.367

10.  The protective effects of the proteasome inhibitor bortezomib (velcade) on ischemia-reperfusion injury in the rat retina.

Authors:  Fang-Ting Chen; Chung-May Yang; Chang-Hao Yang
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.